Cross-source evidence timeline

MK-677 research timeline

Follow 6 selected, directly cited source records from February 20, 2017 through January 27, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

6Selected records
4Source years
2Evidence lanes
January 27, 2026Latest source date

Source year

2026

2 records
  1. Literature metadata

    LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report.↗

    PubMed lists PMID 36303408 in Experimental physiology as Case Reports, Research Support, Non-U.S. Gov't, Journal Article, with publication-date metadata of 2022-11-16 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT05364684↗

    PeptideScanner retained ClinicalTrials.gov record NCT05364684 at 2026-11-16T17:28:23.215Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was mk-677.↗

Source year

2022

2 records
  1. Literature metadata

    Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren.↗

    PubMed lists PMID 34737341 in Nature communications as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-11-04 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren.↗

    PubMed lists PMID 34542924 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2021-12-15 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

1 record
  1. Literature metadata

    Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.↗

    PubMed lists PMID 31964466 in BMB reports as Journal Article, with publication-date metadata of 2020-03 (month precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2017

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00395291↗

    PeptideScanner retained ClinicalTrials.gov record NCT00395291 at 2026-11-16T17:28:23.215Z. Its registry update date was 2017-02-20, and PeptideScanner's reviewed identity mapping was mk-677.↗